Cross-linked glycopeptide-cephalosporin antibiotics

Details Cross-linked glycopeptide-cephalosporin antibiotics Cross-linked glycopeptide-cephalosporin antibiotics

2007-08-24

2010-06-01

Audet, Maury (Department: 1654)

Organic compounds -- part of the class 532-570 series

Organic compounds

Heterocyclic carbon compounds containing a hetero ring...

C540S222000, C540S228000, C514S008100, C514S002600, C514S200000, C435S037000, C435S049000, C436S087000, C530S333000

Reexamination Certificate

active

07728127

ABSTRACT:
This invention provides cross-linked glycopeptide-cephalosporin compounds and pharmaceutically acceptable salts thereof which are useful as antibiotics. This invention also provides pharmaceutical compositions containing such compounds; methods for treating bacterial infections in a mammal using such compounds; and processes and intermediates useful for preparing such compounds.

REFERENCES:
patent: 4284631 (1981-08-01), Takaya et al.
patent: 4293550 (1981-10-01), Blumbach et al.
patent: 4341775 (1982-07-01), Takaya et al.
patent: 4366153 (1982-12-01), Takaya et al.
patent: 4427677 (1984-01-01), Takaya et al.
patent: 4487767 (1984-12-01), Takaya et al.
patent: 4550102 (1985-10-01), Teraji et al.
patent: 4603129 (1986-07-01), Blumbach et al.
patent: 4647556 (1987-03-01), Lattrell et al.
patent: 4667028 (1987-05-01), Schwab et al.
patent: 4668783 (1987-05-01), Ochiai et al.
patent: 4840945 (1989-06-01), Ohnishi et al.
patent: 4921851 (1990-05-01), Kishimoto et al.
patent: 4943567 (1990-07-01), Nishizawa et al.
patent: 6878686 (2005-04-01), Marquess et al.
patent: 6974797 (2005-12-01), Fatheree et al.
patent: 6995138 (2006-02-01), Marquess et al.
patent: 7341993 (2008-03-01), Fatheree et al.
patent: 7553962 (2009-06-01), Fatheree et al.
patent: 7601690 (2009-10-01), Fatheree et al.
patent: 7649080 (2010-01-01), Fatheree et al.
patent: 7655621 (2010-02-01), Fatheree et al.
patent: 2005/0239691 (2005-10-01), Fatheree et al.
patent: 2006/0025332 (2006-02-01), Marquess et al.
patent: 2008/0194465 (2008-08-01), Fatheree et al.
patent: 2 033 377 (1980-05-01), None
patent: 60-41682 (1985-03-01), None
patent: WO 97/41128 (1997-11-01), None
patent: WO 99/64049 (1999-12-01), None
http://cancerweb.ncl.ac.uk/cgi-bin/omd?query=phenylene.
http://en.wikipedia.org/wiki/Substitution—reaction.
http://en.wikipedia.org/wiki/Functional—group.
Nishimura at al., “Studies on condensed-heterocyclic azolium cephalosporins III. Synthesis and antibacterial activity of 7β[2-(2-amino-5-substituted-thiazol-4-yl)-2(Z)-alkoxyiminoacetamido]-3-(condensed-heterocyclic azolium)methyl-3-cephern-4-carboxylates”, The Journal of Antibiotics, vol. 45 No. 4, pp. 485-499 (1991).
Kim, M. et al., “Synthesis and Antibacterial Activity of Cephalosporins Having Hydroxamic Acid at C-7 Position.” Biorganic & Med. Chem. Letters. vol. 6, No. 17, pp. 2077-2080 (1996).
Lattrell, R. et al.. “Synthesis and Structure-Activity Relationships in the Cefpirome Series.” Journal of Antibiotics, vol. XLI, No. 10, pp. 1374-1394.
U.S. Appl. No. 09/457,926, filed Dec. 8, 1999, Christensen et al.

Affiliated with

Also associated with

Rating

Cross-linked glycopeptide-cephalosporin antibiotics does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Cross-linked glycopeptide-cephalosporin antibiotics, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cross-linked glycopeptide-cephalosporin antibiotics will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4192854